ARCHIVES

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

New Guidelines Developed For Cancer Control Granters For Community Outreach

June 4, 1976

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

New Organ Systems Program Coordinating Center RFA Released

April 1, 1983

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

September 10, 1976

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993